About NightHawk Biosciences
NightHawk Biosciences is a company based in Morrisville (United States) founded in 2008. NightHawk Biosciences has raised $8.13 million across 9 funding rounds from investors including HHS. NightHawk Biosciences has completed 1 acquisition, including Pelican Therapeutics. NightHawk Biosciences operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Morrisville, United States
- Stage Public
- SectorsHealthcare
- Website nighthawkbio.com
- Annual Revenue$6.24 M (USD)-59as on Dec 31, 2024
- Net Profit-$32.81 M (USD)-1930as on Dec 31, 2024
- EBITDA-$33.6 M (USD)20as on Dec 31, 2024
- Total Equity Funding$8.13M (USD)
in 9 rounds
- Latest Funding Round$399.11K (USD), Grant
Sep 2023
- Investors
- Investments & Acquisitions
Funding Insights of NightHawk Biosciences
NightHawk Biosciences has successfully raised a total of $8.13M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $399.11 thousand completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.13M
- Total Rounds 9
- Last Round Grant — $399,110
- First Round $249,750
(Nov 2009)
- Investors Count 1
All 9 funding rounds of NightHawk Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in NightHawk Biosciences
NightHawk Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for NightHawk Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NightHawk Biosciences
16 people are tracked at NightHawk Biosciences (4 in leadership, 9 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
William L. Ostrander | Chief Financial Officer | Leadership |
Gary Vinson | VP, Chemistry & Manufacturing Controls | Leadership |
Jeffrey Wolf | Founder & CEO | Leadership |
George Peoples | Chief Medical Advisor | Leadership |
Anthony Tolcher | Scientific Advisor | Board & advisors |
Robert S. Negrin | Scientific Advisor | Board & advisors |
John Prendergast | Director | Board & advisors |
Gary Acton | Scientific Advisor | Board & advisors |
Edward B. Smith III | Director | Board & advisors |
Robert B. Levy | Scientific Advisor | Board & advisors |
Llew Keltner | Scientific Advisor | Board & advisors |
Roger B. Cohen | Scientific Advisor | Board & advisors |
John Monahan | Director | Board & advisors |
Cheni Kwok | Senior Business Development Advisor | Team |
Jen Kelley | Accounting Manager | Team |
Joyanne K. | Accounts Payable Manager | Team |
Complete people profiles for NightHawk Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NightHawk Biosciences
NightHawk Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pelican Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developing antibody to stimulate memory CD8+ cytotoxic T cells for the treatment of cancer. | pelicantherapeutics.com | Austin, United States | 2011 | Mar 2017 | •••• |
Complete acquisition details for NightHawk Biosciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NightHawk Biosciences
5 dated milestones of NightHawk Biosciences across 15 years, from founding to its latest funding, stage changes and deals.
- Founded NightHawk Biosciences is founded.
- Funding First funding round of $250K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Pelican Therapeutics.
- Funding Latest funding round, Grant, of $399K.
Competitors of NightHawk Biosciences
NightHawk Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of NightHawk Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nighthawk Biosciences
Complete news archive for NightHawk Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NightHawk Biosciences
10 companies that operate in the same segment as NightHawk Biosciences (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NightHawk Biosciences
NightHawk Biosciences was founded in 2008 and raised its 1st funding round 1 year after it was founded.
NightHawk Biosciences is headquartered in Morrisville, United States.
NightHawk Biosciences is a funded company, having raised a total of $8.13M across 9 funding rounds to date. The company's 1st funding round was a Seed of $249.75K, raised on Nov 2009.
Annual revenue of NightHawk Biosciences is $6.24M as on Dec 31, 2024.
NightHawk Biosciences was founded in 2008 as a fully integrated biopharmaceutical company based in Morrisville, United States. Operations focus on the discovery, development, and commercialization of therapies in the biotechnology sector. Services encompass preclinical and clinical-stage programs targeting various diseases, with activities managed from U.S. facilities. The companys domain is nighthawkbio.com, supporting its pipeline advancement.
NightHawk Biosciences's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
NightHawk Biosciences has made 1 acquisition, including Pelican Therapeutics.
NightHawk Biosciences has 1 investor. Key investors include HHS.